Dr. Rajeev Kumar (also known as Rajeev K. Singla) is an assistant researcher at the Institutes for Systems Genetics, West China Hospital, Sichuan University. He has extensive experience in the fields of natural products, metabolic disorders, neurological diseases, infectious diseases, cheminformatics, and public health. He is one of the founder and Editor-in-Chief of Indo Global Journal of Pharmaceutical Sciences, Associate Editor of Journal of Translational Medicine, Journal of Alzheimer’s Disease, Frontiers in Pharmacology, and Frontiers in Nutrition, a member of the Topical Advisory Panel of Cancers (MDPI), a member of the Advisory Board of Heliyon (Cell Press), and a member of the Editorial Board of BMC Complementary Medicine and Therapies and CNS & Neurological Disorders - Drug Targets. He is among the top 2% of scientists according to Stanford University, Scopus, and Elsevier reports (based on publications in 2022, 2023, and 2024). He has published more than 140 papers including International Journal of Surgery, Phytomedicine, and Neuroscience and Biobehavioral Reviews. He serves as an expert reviewer for the Sichuan University Innovation Training Program Academy and participates in guiding the College Students Innovation and Entrepreneurship Competition. In addition, he was awarded the 2024 Sichuan Province Foreign High-level Talent Certificate this year and won the second prize for the 2022-2023 Suzhou Natural Science Excellent Academic Paper Award (SZLW2024084).